Antidepressant Use:
Information
on the FDA Health Advisory
On March 22,
2004 the Food & Drug Administration (FDA) released a health advisory warning
concerning the use of the newer antidepressant medications. Before an antidepressant
drug is made available to the public, it is subjected to several clinical trials
assessing the medication’s effectiveness and safety. The warning was based on
a recent review of clinical trials and other reports examining the use of antidepressant
drugs with children. According to the FDA, although no suicides occurred during
the clinical trials, concerns have been raised about potential suicidal thoughts
and behaviors that reportedly occurred during the clinical trials. The FDA is
planning to conduct a more thorough review. In the meantime, they are urging
medical practitioners, parents, and patients to be more vigilant about monitoring
any increase in depressive symptoms including suicidal thoughts and behaviors
among persons taking antidepressants. If you are experiencing suicidal thoughts
or behaviors contact your physician or mental health provider immediately.
If you are
currently taking antidepressant medication this warning does not mean that you
should stop or that you should not consider taking antidepressants to treat
depression. If you are experiencing depressive symptoms, you are more likely
to experience a reduction in your symptoms if you take antidepressant medication
rather than no medication at all. There is still a greater risk of suicide for
depression that is untreated. To read more about the FDA’s report select the
link below.
If you have any questions or concerns or in the event of an emergency,
please contact Counseling and Consultation at (480) 965-6146.
After hours contact EMPACT at 480-921-1006 or call 911.